Markets declined sharply on Tuesday due to weak global cues, with the Nifty retesting crucial support near 25,400. Several stocks like IRFC...

On Monday, Alembic Pharmaceuticals saw a surge in its stock prices after the USFDA greenlit its Diltiazem Hydrochloride Tablets, a crucial ...

Piramal Enterprises Board approved the issuance of secured, rated, listed, and redeemable non-convertible debentures (NCDs) worth up to Rs ...

Piramal Enterprises announced that the administrative committee of its board of directors will meet on December 20 to consider public issua...

Larsen and Toubro (L&T) has overturned a Rs 702 crore customs duty demand following a favourable ruling from the Central Excise & Service T...

Equity markets experienced pressure on monthly expiry day, slipping nearly half a percent. Shares of Tata Investment, Narayana Hrudalaya, H...

Stocks in news: The domestic market edged higher for the second week, moving closer to record highs. Key shares like Trent, BEL, and LTIMin...

Gensol Engineering has won Gujarat Urja Vikas Nigam's 70 mw battery energy storage project, which is worth Rs 450 crore in revenues.

Alembic Pharma has reported a Q1 net profit of INR 121 crore, up from a net loss of INR 66 crore YoY, led by increased sales growth across ...

Alembic Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Royalty Income and Other Operating R...

Earlier this month, the US drug regulator had issued a ‘Form 483’ to the facility of the drug company with five observations.

Alembic Pharma manufactures and markets generic pharmaceutical products across the globe.

The company had posted a consolidated PAT of Rs 200.09 crore in the same quarter last fiscal.

The co said it has also allotted 2,000, 9% rated unsecured listed redeemable NCDs

USFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determine...

Last week, Lupin, Cadila Healthcare and Alembic Pharma received clearances from the US regulator for their key facilities.

Even as stories of various companies benefiting from vast land banks have almost dried up, talks that pharma company Alembic is looking to ...